The placebo effect on systolic, diastolic and pulse arterial pressure;L'effet placebo sur les pressions artérielles systolique, diastolique et pulsée

Presse Medicale

Volumn 31, Issue 26, 2002, Pages 1220-1223

  Queneau, P ^a   Asmar, R ^a   Safar, M ^a  

^a SERVICE DE NEUROLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

AGING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; PREDICTION; PULSE PRESSURE; REVIEW; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; BRAIN STEM; CLINICAL TRIALS; DIASTOLE; HEART; HUMANS; PLACEBO EFFECT; PULSE; SYSTOLE;

EID: 0037055632     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. The powerful placebo
2. The placebo effect in cardiovascular disease
3. Blood pressure, stroke, and coronary heart disease: Part 2. Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context
4. Department of Veteran affairs single therapy of hypertension study. Revised figures and new data
5. A multicenter, double-blind, randomized, placebo controlled study of isradipine and methyldopa as monotherapy or in combination with captopril in the treatment of hypertension
6. Antihypertensive efficacy of cilazapril 2.5 and 5.0 mg once-daily versus placebo on office blood pressure and 24-hour blood pressure profile
7. Losartan with hydrochlorothiazide in the treatment of hypertension
8. Lack of placebo effect on ambulatory blood pressure
9. Effect of placebo on 24-hour non-invasive ambulatory blood pressure
10. Effect of placebo on office and on 24 hour noninvasive ambulatory blood pressure measurements
11. Through-to-peak ratio of indapamide 1.5 mg sustained-release coated tablets assessed by ambulatory blood pressure monitoring
12. Influence of observer's expectation on the placebo effect in blood pressure trials
13. Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension
14. Le placebo est-il nécessaire dans un essai clinique sur la pression artérielle ambulatoire?
15. Guidelines for the management of hypertension
16. Effects of treatment in morbidity in hypertension. Results in patients with diastolic blood pressure averaging 115 through 129 mmHg
17. The effect of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: A revew of randomized controlled trials
18. Prognostic factors in the treatment of mild hypertension
19. Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension
20. A new approach to assessing antihypertensive therapy: Effect of treatment on pulse pressure
21. Drug treatment of hypertension: The reduction of pulse pressure does not necessarily parallel that of systolic and diastolic blood pressure
22. Gender influence on the dose-ranging of a low dose perindopril-indapamide combination in hypertension: Effect on systolic and pulse pressure
23. The placebo effect in heart failure
24. Placebo treatment in congestive heart failure
25. Pulse pressure changes with six classes of antihypertensive agents in a randomized controlled trial
26. The importance of the placebo effects in pain treatment and research
27. The mechanism of placebo analgesia
28. Narcotic receptor blockade and its effect on the analgesic response to placebo and ibuprofen after oral surgery
29. Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors
30. Aortic pulse wave velocity predicts cardiovascular mortality in subjects< 70 years of age